Alpha Tau Medical Ltd.

Healthcare

NASDAQ:DRTS · NASDAQ Capital Market

Market Cap $883.39M Beta 1.20 P/E (TTM) -15.2

$9.78 +0.42%

+$0.04 today

52W Low $2.85High $11.62

Vol 0.57M · Avg 0.69M

EPS (TTM) -$0.63Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+227.09%

Period High

$11.18

Period Low

$2.90

Latest

$9.78

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Alto Neuroscience, Inc.

NYSE:ANRO

$773.12M

Candel Therapeutics, Inc.

NASDAQ:CADL

$438.11M

DBV Technologies S.A.

NASDAQ:DBVT

$383.59M

Amarin Corporation plc

NASDAQ:AMRN

$333.61M

Cellectis S.A.

NASDAQ:CLLS

$311.80M

DiaMedica Therapeutics Inc.

NASDAQ:DMAC

$305.79M

Larimar Therapeutics, Inc.

NASDAQ:LRMR

$300.81M

AC Immune S.A.

NASDAQ:ACIU

$240.19M

Aldeyra Therapeutics, Inc.

NASDAQ:ALDX

$116.72M

Genelux Corporation

NASDAQ:GNLX

$107.96M

What is the latest DRTS filing?

The latest filing shown is 6-K dated Jun 11, 2026.

How many recent filings does DRTS have?

Intrinsic Alpha currently shows 20 recent filings for DRTS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.